๐Ÿ”ฅ Black Friday Sale: Save 30% or more on all Examine products Learn more ยป

Studies related to C-Reactive Protein (CRP) and L-Carnitine

L-Carnitine Supplementation For Adults With End-stage Kidney Disease Requiring Maintenance Hemodialysis: A Systematic Review And Meta-analysis

Effect Decrease
Trial Design Meta analysis
Trial Length n/a
Number of Subjects 31
Sex n/a
Notes for this study:
When assessing all trials in persons on maintenance dialysis using supplementation of L-carnitine (any form) for a duration longer than two weeks, it was confirmed that there was a reduction in LDL cholesterol (not deemed clinically significant but reaching a mean reduction of โˆ’5.82mg/dL) and a reduction in C-reactive protein (clinically significant, a reduction of โˆ’3.65mg/L) although no other biomarker including those relating to erythropoietin dosage and hematocrit were affected.

No adverse effects of L-carnitine supplementation were reported in any trial.

Full details on all 12 studies are available to Examine members โ€” On Sale for Black Friday! .

Already a Member? Log in now to access.